logo
Yieldstreet and Upgrade Partner to Expand Access to Consumer Credit Investing

Yieldstreet and Upgrade Partner to Expand Access to Consumer Credit Investing

Business Wire28-04-2025

NEW YORK--(BUSINESS WIRE)--Yieldstreet, a leading private markets investing platform, and Upgrade Inc., a fintech company offering affordable and responsible credit products to mainstream consumers, today announced the completion of an agreement to purchase assets through Flex Pay, Upgrade's BNPL financing solution. This partnership enables individual investors to target passive income from exposure to high-quality consumer BNPL loans.
The first transaction, which closed in April 2025, includes a pool of travel loans through Flex Pay's strong partnerships with over 750 travel partners, including major airlines, cruise lines, and hotel chains.
"Upgrade has established itself as a market leader in a wide range of credit categories, including BNPL travel-related financing, with its robust origination platform," said Ted Yarbrough, President and Chief Investment Officer at Yieldstreet. "We're pleased to complete this transaction which will allow investors to further diversify their portfolios in private markets with exposure to consumer credit."
'Through this collaboration with Upgrade, we're continuing to expand Yieldstreet's private credit offerings with another asset class that provides exposure to a diverse portfolio of consumer obligations capitalizing on strong demand for travel experiences even in the face of the volatility currently being experienced in public markets,' said Fahd Basir, Head of Credit and Opportunistic Investments at Yieldstreet.
'We're excited to partner with Yieldstreet to give more investors access to this rapidly-growing asset class,' said Renaud Laplanche, CEO and Co-founder, Upgrade. 'Flex Pay presents a differentiated opportunity for investors and brings more affordability and flexibility to consumers.'
Flex Pay's travel financing services are integrated into checkout pages for major brands including United Airlines (NYSE: UAL), Southwest Airlines (NYSE: LUV), Norwegian Cruise Line (NYSE: NCLH), Carnival Cruise Line (NYSE: CCL), and Wyndham Hotels (NYSE: WH).
The platform allows travelers to finance trips with fixed monthly payments, targeting consumers who choose the service for convenience and flexibility as opposed to actively seeking credit. As of April 2025, over $37 billion in loans for more than 6.5 million customers has been originated through Upgrade since its founding, including $6.7 billion in Flex Pay travel financing.
Yieldstreet's platform has facilitated over $6 billion in investments to date, providing individual investors with access to asset classes typically available only to institutions. This transaction marks the addition of travel financing to Yieldstreet's growing portfolio of private market opportunities.
About Yieldstreet
With more than 500,000 members, Yieldstreet is reimagining how wealth is created, helping investors diversify their portfolios with assets spanning real estate, private credit, private equity, art and more. Its award-winning platform offers investments across ten asset classes. For more information, visit www.yieldstreet.com.
About Upgrade
Upgrade, Inc. offers affordable and responsible credit, mobile banking and payment products to mainstream consumers. Upgrade has delivered over $37 billion in affordable and responsible credit to customers since its inception in 2017. The company's headquarters are in San Francisco, California, with an operations center in Phoenix, Arizona, a technology center in Montreal, Canada, and regional offices in Atlanta, Georgia, and Irvine, California. Upgrade is a financial technology company, not a bank. More information is available at: www.upgrade.com.
Loans made through Flex Pay are offered by these lending partners.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This Ultra-High Dividend Yield Stock Is Crushing the Market in 2025: But Is It a Buy Today?
This Ultra-High Dividend Yield Stock Is Crushing the Market in 2025: But Is It a Buy Today?

Yahoo

time37 minutes ago

  • Yahoo

This Ultra-High Dividend Yield Stock Is Crushing the Market in 2025: But Is It a Buy Today?

Altria's cigarette volume declines are accelerating, but it's maintaining earnings growth through price increases. The company is trying to grow with new nicotine products, but it has struggled against the competition. The stock has a high dividend yield, but the business looks to be at risk over the next 10 years. 10 stocks we like better than Altria Group › In times of turmoil and uncertainty, investors often flock to consumer staples. That has occurred yet again in 2025. Altria Group (NYSE: MO) has posted a total return of 17% year to date, compared to a measly 2% return for the S&P 500 index. With domestic rights to the tobacco brand Marlboro, among other assets, the company has long been a reliable dividend stock, and it boasts a sky-high dividend yield of 6.8% as of this writing. Should you buy shares of Altria Group to ride out market volatility? Here are the positives and negatives of owning the tobacco stock right now. The largest selling point against Altria Group and its cigarette business is the rapidly declining usage of cigarettes in the United States. While good for society, it is a headwind to Altria's bottom line, with gradually declining demand for the company's core product. And this trend may be accelerating as Marlboro volumes fell 13% year over year last quarter, one of the worst volume performances in the company's history. Altria has been able to counteract volume declines with price increases. Smokeable net revenue after excise taxes only dipped 4.1% last quarter with operating income up 1.2% to $2.47 billion. Altria has long been able to prop up its bottom line despite the shrinking pool of smokers in the United States. It reported $11.62 billion of consolidated operating income over the past 12 months, a figure that has held relatively steady over the last five years. Just because cigarette usage in the U.S. is declining, however, does not mean nicotine usage is down. New forms of nicotine consumption have popped up in recent years, such as electronic vapor and tobacco-free nicotine pouches. Altria has made numerous investments into these product categories. It now owns the NJOY vaping brand, which is growing market share in the U.S. (6.6% as of last quarter). Revenue and earnings from NJOY are not disclosed today, but it is a growing brand for Altria that can help make up for lost cigarette customers. Altria also owns the On! pouch brand, which grew shipment volumes 18% last quarter to 39.3 million. One problem remains, though: It's well behind other tobacco giants in building these new nicotine businesses. For example, On! competitor Zyn, owned by Philip Morris International, is growing faster and has much larger market share. Zyn shipment volume in the United States was 202 million last quarter, up from 132 million a year ago. That means Zyn added more than the entire quarterly On! shipment volume in just one year. Altria is behind its peers in non-tobacco nicotine, and that's not a great place for the business to be in. Altria's dividend currently yields 6.8%, enough to generate a substantial amount of annual income. For example, if you own $10,000 of Altria stock, you would receive about $680 in dividend income for the year (before taxes). That amount will likely grow over time as well. But how sustainable is this dividend with the company facing weakening demand for its biggest product? Altria pays an annualized dividend per share of $4.04, while its free cash flow per share is $4.97, or 23% larger than the payout. Free cash flow is the core metric here since it represents the company's operating cash flow, less capital expenditures (money reinvested into the business). The cushion between Altria's dividend payments and free cash flow leaves it with some flexibility to maintain and grow its annual payout. At the same time, management is repurchasing stock, which reduces its outstanding share count and the total amount paid out in dividends each quarter. So, in the short run, Altria Group should have no trouble maintaining its dividend, but it's the long run that concerns me. Record cigarette volume declines will catch up with the company eventually, and anyone looking to hold the stock for years of steady, passive income is facing this major risk. That's why I suggest avoiding Altria Group stock, even with its market-beating yield. Before you buy stock in Altria Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Altria Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool recommends Philip Morris International. The Motley Fool has a disclosure policy. This Ultra-High Dividend Yield Stock Is Crushing the Market in 2025: But Is It a Buy Today? was originally published by The Motley Fool Sign in to access your portfolio

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

Associated Press

time42 minutes ago

  • Associated Press

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the 'Class Period'), of the important July 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased DoubleVerify common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the DoubleVerify class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) DoubleVerify's customers were shifting their ad spending from open exchanges to closed platforms, where DoubleVerify's technological capabilities were limited and competed directly with native tools provided by platforms like Meta Platforms and Amazon; (2) DoubleVerify's ability to monetize on Activation Services, DoubleVerify's high-margin advertising optimization services segment, was limited because the development of its technology for closed platforms was significantly more expensive and time-consuming than disclosed to investors; (3) DoubleVerify's Activation Services in connection with certain closed platforms would take several years to monetize; (4) DoubleVerify's competitors were better positioned to incorporate AI into their offerings on closed platforms, which impaired DoubleVerify's ability to compete effectively and adversely impacted DoubleVerify's profits; (5) DoubleVerify systematically overbilled its customers for ad impressions served to declared bots operating out of known data center server farms; (6) DoubleVerify's risk disclosures were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities; and (7) as a result of the foregoing, defendants' positive statements about DoubleVerify's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the DoubleVerify class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ______________________ Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]

Amerant Bancorp (NYSE:AMTB) shareholders have endured a 38% loss from investing in the stock three years ago
Amerant Bancorp (NYSE:AMTB) shareholders have endured a 38% loss from investing in the stock three years ago

Yahoo

timean hour ago

  • Yahoo

Amerant Bancorp (NYSE:AMTB) shareholders have endured a 38% loss from investing in the stock three years ago

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Amerant Bancorp Inc. (NYSE:AMTB) shareholders, since the share price is down 41% in the last three years, falling well short of the market return of around 57%. Furthermore, it's down 22% in about a quarter. That's not much fun for holders. With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Over the three years that the share price declined, Amerant Bancorp's earnings per share (EPS) dropped significantly, falling to a loss. Due to the loss, it's not easy to use EPS as a reliable guide to the business. However, we can say we'd expect to see a falling share price in this scenario. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Amerant Bancorp's TSR for the last 3 years was -38%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! While the broader market gained around 12% in the last year, Amerant Bancorp shareholders lost 18% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 5%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Amerant Bancorp you should know about. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store